Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)

2005859 citationsJournal Article

Authors

Infliximab was well tolerated and effective in a large cohort of patients with AS during a 24-week study period.

Partnerships for the goals

Published in: Arthritis & Rheumatism

Volume 52, Issue 2, pp. 582-591

Field-Weighted Citation Impact: 38.71